Private-equity-backed Curium Pharma offers to buy Lantheus in a $7 billion deal.
Lantheus Holdings, a company focusing on radiopharmaceuticals, is considering a possible sale after receiving a takeover offer from Curium Pharma, a private equity firm, valued

